Active Ingredient History

NOW
  • Now
Gliquidone is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).   Wikipedia

  • SMILES: COc1ccc2c(c1)C(=O)N(CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4)C(=O)C2(C)C
  • InChIKey: LLJFMFZYVVLQKT-UHFFFAOYSA-N
  • Mol. Mass: 527.64
  • ALogP: 3.52
  • ChEMBL Molecule:
More Chemistry
1-cyclohexyl-3-(p-beta-(4,4- dimethyl-2-methoxy-1,3-(2h,4h)-isoquinolinedione- 2-yl)phenethyl)sulfonylurea | ar-df 26 | ardf-26 | beglynor | beglynora | glikvidon | gliquidone | gliquidone calcium | gliquidone, calcium salt | gliquidone monosodium | gliquidone, monosodium salt | gliquidone sodium | glurenor | glurenorm | glycvidon | sanofi synthelabo brand of gliquidone | yamanouchi brand of gliquidone

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue